Health care disparities involved in establishing functional arteriovenous fistula hemodialysis access

Shannon M McDonnell1, Jonah Frueh1, Matthew Blecha2

  • 1Loyola University Medical Center, Stritch School of Medicine, Maywood, IL.

Insights

Black patients undergoing hemodialysis face higher risks for additional arteriovenous fistula (AVF) procedures. This study highlights racial disparities in AVF maturation, necessitating further research to ensure equitable care.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Health Disparities Research

Background:

  • Cardiovascular disease outcomes show documented race-related disparities.
  • Arteriovenous fistula (AVF) maturation is critical for hemodialysis access in end-stage renal disease (ESRD) patients.
  • Challenges in AVF maturation can lead to increased need for interventions.

Purpose of the Study:

  • To investigate the incidence of procedures needed for AVF maturation.
  • To evaluate the association between demographic factors, specifically patient race, and the need for interventions.
  • To identify racial disparities in AVF access maintenance and creation.

Main Methods:

  • Single-institution retrospective review of 669 patients undergoing first-time AVF creation for hemodialysis (2007-2021).
  • Recorded subsequent arteriovenous access interventions (e.g., angioplasty, surgical revision, thrombectomy).
  • Multivariable analysis assessed the need for and number of interventions based on demographic data, including race.

Main Results:

  • Black patients had a significantly higher risk of maintenance interventions (RR, 1.900; P ≤ .0001) and additional AVF creation interventions (RR, 1.332; P = .05) compared to White patients.
  • Overall, Black patients required more total interventions (RR, 1.551; P ≤ .0001).
  • 53.1% of patients required no additional procedures, while 46.9% required one or more.

Conclusions:

  • Black patients exhibit a significantly higher risk for additional surgical procedures related to AVF maintenance and creation.
  • These findings underscore critical racial disparities in vascular access for hemodialysis.
  • Further research is essential to understand the root causes and achieve equitable outcomes across racial groups.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
77
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
43
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
57
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
57
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
396
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
48